Skip to main content
Top
Published in: BMC Complementary Medicine and Therapies 1/2020

Open Access 01-12-2020 | Myocardial Infarction | Research article

Network pharmacology exploration reveals a common mechanism in the treatment of cardio-cerebrovascular disease with Salvia miltiorrhiza Burge. and Carthamus tinctorius L

Authors: Yu Wang, Yajun Shi, Junbo Zou, Xiaofei Zhang, Yulin Liang, Jia Tai, Chunli Cui, Mei Wang, Dongyan Guo

Published in: BMC Complementary Medicine and Therapies | Issue 1/2020

Login to get access

Abstract

Background

This study aimed to identify the key genes and KEGG pathways in Carthamus tinctorius L. (Safflower) and Salvia miltiorrhiza Burge. (Salvia) for the treatment of cardio-cerebrovascular disease, and to explore their potential molecular mechanisms.

Methods

Compounds and targets in Safflower and Salvia were retrieved from Traditional Chinese Medicine Systems Pharmacology Database and Analysis Platform (TCMSP). We obtained targets of myocardial infarction (MI) and cerebral infarction (CI) data from Therapeutic Target Database (TTD), Drugbank and DisGeNET datasets. The network of Safflower, Salvia, CI and MI was established and then executing, and Kyoto Encyclopedia of Genes and Genomes (KEGG) and Gene Ontology (GO) analyses of the functional characteristics were performed. The Chinese herbal prescription and target for CI and MI were obtained by searching in the database. Finally, the main pathways of Salvia and Safflower in Chinese patent medicines were analyzed. The MCAO model was established in rats, and compatibility of salvia with safflower was experimentally verified.

Results

We obtained a total of 247 genes targeted by 52 compounds from Safflower and 119 genes targeted by 48 compounds from Salvia. In total, we identified 299 known therapeutic targets for the treatment of CI and 960 targets for the treatment MI. There are 23 common targets for Salvia, Safflower, MI, and CI. A total of 85 KEGG pathways were also enriched and intersected with the pathway of proprietary Chinese medicine to yield 25 main pathways. Safflower and Salvia have the best therapeutic effect in MCAO.

Conclusion

We identified gene lists for Safflower and Salvia in CI and MI. Bioinformatics and interaction analyses may provide new insight into the treatment of cardio-cerebrovascular diseases with Safflower and Salvia.
Literature
1.
go back to reference Meng C, Piwen Z, Yanlin S, Liping S. Advances in pharmacological function of Carthamus tinctorius and its essential constitutes. Glob Tradit Chin Med. 2012;5(07):556–60. Meng C, Piwen Z, Yanlin S, Liping S. Advances in pharmacological function of Carthamus tinctorius and its essential constitutes. Glob Tradit Chin Med. 2012;5(07):556–60.
2.
go back to reference Le-Le Z, Ke T, Zheng-Hai T, Xiao-Jia C, Zhao-Xiang B, Yi-Tao W, et al. Phytochemistry and pharmacology of Carthamus tinctorius L. Am J Chin Med. 2016;44:2. Le-Le Z, Ke T, Zheng-Hai T, Xiao-Jia C, Zhao-Xiang B, Yi-Tao W, et al. Phytochemistry and pharmacology of Carthamus tinctorius L. Am J Chin Med. 2016;44:2.
3.
go back to reference Shan-yong YI, Li-li GUAN, Jing YANG, Hai-yan LI, Xiao-kun LI, Chao JIANG. HUANG, research advances in pharmacological function and development and application of Carthamus tinctoriu L. Nor Horticul. 2015;05:191–5. Shan-yong YI, Li-li GUAN, Jing YANG, Hai-yan LI, Xiao-kun LI, Chao JIANG. HUANG, research advances in pharmacological function and development and application of Carthamus tinctoriu L. Nor Horticul. 2015;05:191–5.
4.
go back to reference Li ZM, Xu SW, Liu PQ. Salvia miltiorrhizaBurge (Danshen): a golden herbal medicine in cardiovascular therapeutics. Acta Pharmacol Sin. 2018;39(5):802–24.CrossRef Li ZM, Xu SW, Liu PQ. Salvia miltiorrhizaBurge (Danshen): a golden herbal medicine in cardiovascular therapeutics. Acta Pharmacol Sin. 2018;39(5):802–24.CrossRef
5.
go back to reference Pang H, Wu L, Tang Y, Zhou G, Qu C, Duan JA. Chemical analysis of the herbal medicine Salviae miltiorrhizae radix et Rhizoma (Danshen). Molecules. 2016;21(1):51.CrossRef Pang H, Wu L, Tang Y, Zhou G, Qu C, Duan JA. Chemical analysis of the herbal medicine Salviae miltiorrhizae radix et Rhizoma (Danshen). Molecules. 2016;21(1):51.CrossRef
6.
go back to reference Su CY, Ming QL, Rahman K, Han T, Qin LP. Salvia miltiorrhiza: traditional medicinal uses, chemistry, and pharmacology. Chin J Nat Med. 2015;13(3):163–82.PubMed Su CY, Ming QL, Rahman K, Han T, Qin LP. Salvia miltiorrhiza: traditional medicinal uses, chemistry, and pharmacology. Chin J Nat Med. 2015;13(3):163–82.PubMed
7.
go back to reference Wang JF, Wei DQ, Chou KC. Drug candidates from traditional chinese medicines. Curr Top Med Chem. 2008;8(18):1656–65.CrossRef Wang JF, Wei DQ, Chou KC. Drug candidates from traditional chinese medicines. Curr Top Med Chem. 2008;8(18):1656–65.CrossRef
8.
go back to reference Cao W, Guo XW, Zheng HZ, Li DP, Jia GB, Wang J. Current progress of research on pharmacologic actions of salvianolic acid B. Chin J Integr Med. 2012;18(4):316–20.CrossRef Cao W, Guo XW, Zheng HZ, Li DP, Jia GB, Wang J. Current progress of research on pharmacologic actions of salvianolic acid B. Chin J Integr Med. 2012;18(4):316–20.CrossRef
9.
go back to reference X Z. On simultaneous treatment of heart and brain. Chin Arch Tradit Chin Med. 2005;10:1895–6. X Z. On simultaneous treatment of heart and brain. Chin Arch Tradit Chin Med. 2005;10:1895–6.
10.
go back to reference Pang SC, Zhang JP. Theory and application of simultaneous treatment of heart and brain. J Tradit Chin Med. 2012;53(07):555–7. Pang SC, Zhang JP. Theory and application of simultaneous treatment of heart and brain. J Tradit Chin Med. 2012;53(07):555–7.
11.
go back to reference Chen D, Tang SH, Lu P, Yang HJ. Mechanism of “treating heart and brain with same methods” based on data science. Zhongguo Zhong Yao Za Zhi. 2015;40(21):4288–96.PubMed Chen D, Tang SH, Lu P, Yang HJ. Mechanism of “treating heart and brain with same methods” based on data science. Zhongguo Zhong Yao Za Zhi. 2015;40(21):4288–96.PubMed
12.
go back to reference Hu T, Wei G, Xi M, Yan J, Wu X, Wang Y, et al. Synergistic cardioprotective effects of Danshensu and hydroxysafflor yellow a against myocardial ischemia-reperfusion injury are mediated through the Akt/Nrf2/HO-1 pathway. Int J Mol Med. 2016;38(1):83–94.CrossRef Hu T, Wei G, Xi M, Yan J, Wu X, Wang Y, et al. Synergistic cardioprotective effects of Danshensu and hydroxysafflor yellow a against myocardial ischemia-reperfusion injury are mediated through the Akt/Nrf2/HO-1 pathway. Int J Mol Med. 2016;38(1):83–94.CrossRef
13.
go back to reference Deng JG, Zhang DW, Li J. Experimental study on the effects of water soluble components and compatibility of salvia miltiorrhiza and safflower on myocardial ischemia / reperfusion injury in rats. Chin J Chin Mater Med. 2011;36(02):189–94. Deng JG, Zhang DW, Li J. Experimental study on the effects of water soluble components and compatibility of salvia miltiorrhiza and safflower on myocardial ischemia / reperfusion injury in rats. Chin J Chin Mater Med. 2011;36(02):189–94.
14.
go back to reference Zhang L, Liu JG, Shi DZ. The protection of active component injection of Slauia miltiorrhiza Bge .And Carthamus tinctorius L .On myocardial Ischemical reperfusion injury in rats. Chin J Exp Tradit Med Formulae. 2009;15(06):37–41. Zhang L, Liu JG, Shi DZ. The protection of active component injection of Slauia miltiorrhiza Bge .And Carthamus tinctorius L .On myocardial Ischemical reperfusion injury in rats. Chin J Exp Tradit Med Formulae. 2009;15(06):37–41.
15.
go back to reference Gao LN, Cui YL, Yan K, Qiu C. Advances in studies on compatibility of Salviae Miltiorrhizae radix et Rhizoma and Carthamii Flos. Chin Tradit Herbal Drugs. 2016;47(04):671–9. Gao LN, Cui YL, Yan K, Qiu C. Advances in studies on compatibility of Salviae Miltiorrhizae radix et Rhizoma and Carthamii Flos. Chin Tradit Herbal Drugs. 2016;47(04):671–9.
16.
go back to reference Committee of National Pharmacopoeia. Pharmacopoeia of People’s republic of China, vol. 1. Beijing: China Medical Science and Technology Press; 2015. Committee of National Pharmacopoeia. Pharmacopoeia of People’s republic of China, vol. 1. Beijing: China Medical Science and Technology Press; 2015.
17.
go back to reference Yu G, Wang LG, Han Y, He QY. clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS. 2012;16(5):284–7.CrossRef Yu G, Wang LG, Han Y, He QY. clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS. 2012;16(5):284–7.CrossRef
18.
go back to reference Alexa A, Rahnenfuhrer J. topGO: enrichment analysis for gene ontology. R package version; 2006. Alexa A, Rahnenfuhrer J. topGO: enrichment analysis for gene ontology. R package version; 2006.
19.
go back to reference Ru J, Li P, Wang J, Zhou W, Li B, Huang C, et al. TCMSP: a database of systems pharmacology for drug discovery from herbal medicines. Aust J Chem. 2014;6:13. Ru J, Li P, Wang J, Zhou W, Li B, Huang C, et al. TCMSP: a database of systems pharmacology for drug discovery from herbal medicines. Aust J Chem. 2014;6:13.
20.
go back to reference Committee of National Pharmacopoeia. Pharmacopoeia of People’s Republic of China. Beijing: China Medical Science and Technology Press; 2015. Part 1, 727. Committee of National Pharmacopoeia. Pharmacopoeia of People’s Republic of China. Beijing: China Medical Science and Technology Press; 2015. Part 1, 727.
21.
go back to reference Committee of National Pharmacopoeia. Pharmacopoeia of People’s Republic of China. Beijing: China Medical Science and Technology Press; 2015. Part 1, 804. Committee of National Pharmacopoeia. Pharmacopoeia of People’s Republic of China. Beijing: China Medical Science and Technology Press; 2015. Part 1, 804.
22.
go back to reference Committee of National Pharmacopoeia. Pharmacopoeia of People’s Republic of China. Beijing: China Medical Science and Technology Press; 2015. Part 1, 972. Committee of National Pharmacopoeia. Pharmacopoeia of People’s Republic of China. Beijing: China Medical Science and Technology Press; 2015. Part 1, 972.
23.
go back to reference Committee of National Pharmacopoeia. Pharmacopoeia of People’s Republic of China. Beijing: China Medical Science and Technology Press; 2015. Part 1, 1296. Committee of National Pharmacopoeia. Pharmacopoeia of People’s Republic of China. Beijing: China Medical Science and Technology Press; 2015. Part 1, 1296.
24.
go back to reference National Medical Prouducts Administration. Standard promulgation of the State Food and Drug Administration. Beijing, 2017; ZGB2017-3. National Medical Prouducts Administration. Standard promulgation of the State Food and Drug Administration. Beijing, 2017; ZGB2017-3.
25.
go back to reference National Medical Prouducts Administration. Standard promulgation of the State Food and Drug Administration. Beijing, 2012; ZD-0487. National Medical Prouducts Administration. Standard promulgation of the State Food and Drug Administration. Beijing, 2012; ZD-0487.
26.
go back to reference Shi M, Huang F, Deng C, Wang Y, Kai G. Bioactivities, biosynthesis and biotechnological production of phenolic acids in Salvia miltiorrhiza. Crit Rev Food Sci Nutr. 2018:1–12. Shi M, Huang F, Deng C, Wang Y, Kai G. Bioactivities, biosynthesis and biotechnological production of phenolic acids in Salvia miltiorrhiza. Crit Rev Food Sci Nutr. 2018:1–12.
27.
go back to reference Li HX, Han SY, Wang XW, Ma X, Zhang K, Wang L, et al. Effect of the carthamins yellow from Carthamus tinctorius L. on hemorheological disorders of blood stasis in rats. Food Chem Toxicol. 2009;47(8):1797–802. Li HX, Han SY, Wang XW, Ma X, Zhang K, Wang L, et al. Effect of the carthamins yellow from Carthamus tinctorius L. on hemorheological disorders of blood stasis in rats. Food Chem Toxicol. 2009;47(8):1797–802.
28.
go back to reference Asgarpanah J, Kazemivash N. Phytochemistry, pharmacology and medicinal properties of Carthamus tinctorius L. Chin J Integr Med. 2013;19(2):153–9. Asgarpanah J, Kazemivash N. Phytochemistry, pharmacology and medicinal properties of Carthamus tinctorius L. Chin J Integr Med. 2013;19(2):153–9.
29.
go back to reference Liu L. Overview of Carthamus tinctorius L. Guangzhou Chemical Industry. 2017;45(12):23–5+68. Liu L. Overview of Carthamus tinctorius L. Guangzhou Chemical Industry. 2017;45(12):23–5+68.
30.
go back to reference Zhang LL, Tian K, Tang ZH, Chen XJ, Bian ZX, Wang YT, et al. Phytochemistry and Pharmacology of Carthamus tinctorius L. Am J Chin Med. 2016;44(2):197–226. Zhang LL, Tian K, Tang ZH, Chen XJ, Bian ZX, Wang YT, et al. Phytochemistry and Pharmacology of Carthamus tinctorius L. Am J Chin Med. 2016;44(2):197–226.
31.
go back to reference Fei YX, Wang SQ, Yang LJ, Qiu YY, Li YZ, Liu WY, et al. Salvia miltiorrhiza Bunge (Danshen) extract attenuates permanent cerebral ischemia through inhibiting platelet activation in rats. J Ethnopharmacol. 2017;207:57–66. Fei YX, Wang SQ, Yang LJ, Qiu YY, Li YZ, Liu WY, et al. Salvia miltiorrhiza Bunge (Danshen) extract attenuates permanent cerebral ischemia through inhibiting platelet activation in rats. J Ethnopharmacol. 2017;207:57–66.
32.
go back to reference Yang G, Wang Y, Zeng Y, Gao GF, Liang X, Zhou M, et al. Rapid health transition in China, 1990-2010: findings from the Global Burden of Disease Study 2010. Lancet. 2013;381(9882):1987–2015. Yang G, Wang Y, Zeng Y, Gao GF, Liang X, Zhou M, et al. Rapid health transition in China, 1990-2010: findings from the Global Burden of Disease Study 2010. Lancet. 2013;381(9882):1987–2015.
33.
go back to reference Jauch EC, Saver JL, Adams HP, Bruno A, Connors JJ, Demaerschalk BM, et al. Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2013;44(3):870–947. Jauch EC, Saver JL, Adams HP, Bruno A, Connors JJ, Demaerschalk BM, et al. Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2013;44(3):870–947.
34.
go back to reference Moore KJ, Tabas I. Macrophages in the pathogenesis of atherosclerosis. Cell. 2011;145(3):341–55. Moore KJ, Tabas I. Macrophages in the pathogenesis of atherosclerosis. Cell. 2011;145(3):341–55.
35.
go back to reference Han JY, Fan JY, Horie Y, Miura S, Cui DH, Ishii H, et al. Ameliorating effects of compounds derived from Salvia miltiorrhiza root extract on microcirculatory disturbance and target organ injury by ischemia and reperfusion. Pharmacol Ther. 2008;117(2):280–95. Han JY, Fan JY, Horie Y, Miura S, Cui DH, Ishii H, et al. Ameliorating effects of compounds derived from Salvia miltiorrhiza root extract on microcirculatory disturbance and target organ injury by ischemia and reperfusion. Pharmacol Ther. 2008;117(2):280–95.
36.
go back to reference Che Y, Ruan Y, Li L, Chu Y, Xu X, Wang Q, et al. Effects of Salvia miltiorrhiza extracts on rat hypoxic pulmonary hypertension, heme oxygenase-1 and nitric oxide synthase. Chin Med J. 2003;116(5):757–60. Che Y, Ruan Y, Li L, Chu Y, Xu X, Wang Q, et al. Effects of Salvia miltiorrhiza extracts on rat hypoxic pulmonary hypertension, heme oxygenase-1 and nitric oxide synthase. Chin Med J. 2003;116(5):757–60.
37.
go back to reference Wang J, Xiong X, Feng B. Cardiovascular effects of salvianolic Acid B. Evid Based Complement Alternat Med. 2013;2013:247948. Wang J, Xiong X, Feng B. Cardiovascular effects of salvianolic Acid B. Evid Based Complement Alternat Med. 2013;2013:247948.
38.
go back to reference He X, Shen Q. Salvianolic acid B promotes bone formation by increasing activity of alkaline phosphatase in a rat tibia fracture model: a pilot study. BMC Complement Altern Med. 2014;14:493. He X, Shen Q. Salvianolic acid B promotes bone formation by increasing activity of alkaline phosphatase in a rat tibia fracture model: a pilot study. BMC Complement Altern Med. 2014;14:493.
39.
go back to reference Lay IS, Chiu JH, Shiao MS, Lui WY, Wu CW. Crude extract of Salvia miltiorrhiza and salvianolic acid B enhance in vitro angiogenesis in murine SVR endothelial cell line. Planta Med. 2003;69(1):26–32. Lay IS, Chiu JH, Shiao MS, Lui WY, Wu CW. Crude extract of Salvia miltiorrhiza and salvianolic acid B enhance in vitro angiogenesis in murine SVR endothelial cell line. Planta Med. 2003;69(1):26–32.
40.
go back to reference Duval F, Moreno-Cuevas JE, González-Garza MT, Rodríguez-Montalvo C, Cruz-Vega DE. Protective mechanisms of medicinal plants targeting hepatic stellate cell activation and extracellular matrix deposition in liver fibrosis. Chin Med. 2014;9(1):27. Duval F, Moreno-Cuevas JE, González-Garza MT, Rodríguez-Montalvo C, Cruz-Vega DE. Protective mechanisms of medicinal plants targeting hepatic stellate cell activation and extracellular matrix deposition in liver fibrosis. Chin Med. 2014;9(1):27.
41.
go back to reference Yang Y, Ge PJ, Jiang L, Li FL, Zhu QY. Modulation of growth and angiogenic potential of oral squamous carcinoma cells in vitro using salvianolic acid B. BMC Complement Altern Med. 2011;11:54. Yang Y, Ge PJ, Jiang L, Li FL, Zhu QY. Modulation of growth and angiogenic potential of oral squamous carcinoma cells in vitro using salvianolic acid B. BMC Complement Altern Med. 2011;11:54.
42.
go back to reference Chang TM, Shi GY, Wu HL, Wu CH, Su YD, Wang HL, et al. Effects of salvianolic Acid B on protein expression in human umbilical vein endothelial cells. Evid Based Complement Alternat Med. 2011;2011:213050. Chang TM, Shi GY, Wu HL, Wu CH, Su YD, Wang HL, et al. Effects of salvianolic Acid B on protein expression in human umbilical vein endothelial cells. Evid Based Complement Alternat Med. 2011;2011:213050.
43.
go back to reference Wei ZY, Xu WJ, Dong JJ. Studies on hydroxysafflower yellow A repairing the metabolic disturbances of early atherosclerosis based on fatty acid profiling. Acta Pharmaceutica Sinica. 2018:1–9. Wei ZY, Xu WJ, Dong JJ. Studies on hydroxysafflower yellow A repairing the metabolic disturbances of early atherosclerosis based on fatty acid profiling. Acta Pharmaceutica Sinica. 2018:1–9.
44.
go back to reference Webster KA, Graham RM, Thompson JW, Spiga MG, Frazier DP, Wilson A, et al. Redox stress and the contributions of BH3-only proteins to infarction. Antioxid Redox Signal. 2006;8(9-10):1667–76. Webster KA, Graham RM, Thompson JW, Spiga MG, Frazier DP, Wilson A, et al. Redox stress and the contributions of BH3-only proteins to infarction. Antioxid Redox Signal. 2006;8(9-10):1667–76.
45.
go back to reference Zhu YL, Liu QQ, Yang WQ. Effects of compound tablet of red sage root on the expression of HIF -1αin brain of rat during chronic cerebral ischemia. J Practical Nerv Dis. 2005;(05):18–9. Zhu YL, Liu QQ, Yang WQ. Effects of compound tablet of red sage root on the expression of HIF -1αin brain of rat during chronic cerebral ischemia. J Practical Nerv Dis. 2005;(05):18–9.
46.
go back to reference Lian Q, Zhao DL, Zhu HB. Hydroxysafflor yellow A up-regulates HIF-1α viainhibition of VHL and p53 in Eahy926 cell line exposed to hypoxi. Acta Pharmaceutica Sinica. 2008(05):484–9. Lian Q, Zhao DL, Zhu HB. Hydroxysafflor yellow A up-regulates HIF-1α viainhibition of VHL and p53 in Eahy926 cell line exposed to hypoxi. Acta Pharmaceutica Sinica. 2008(05):484–9.
47.
go back to reference Um JY, An NH, Kim HM. TNF-alpha and TNF-beta gene polymorphisms in cerebral infarction. J Mol Neurosci. 2003;21(2):167–71.CrossRef Um JY, An NH, Kim HM. TNF-alpha and TNF-beta gene polymorphisms in cerebral infarction. J Mol Neurosci. 2003;21(2):167–71.CrossRef
48.
go back to reference Gao C, Liu Y, Yu Q, Yang Q, Li B, Sun L, et al. TNF-α antagonism ameliorates myocardial ischemia-reperfusion injury in mice by upregulating adiponectin. Am J Physiol Heart Circ Physiol. 2015;308(12):H1583–91.CrossRef Gao C, Liu Y, Yu Q, Yang Q, Li B, Sun L, et al. TNF-α antagonism ameliorates myocardial ischemia-reperfusion injury in mice by upregulating adiponectin. Am J Physiol Heart Circ Physiol. 2015;308(12):H1583–91.CrossRef
49.
go back to reference Li HH, Lou SJ. Effects of hypoxia on the expression of IL-1β、IL-6 and TNF-α mRNA in cerebral cortex cells of rats. Chin J Neuroanat. 2013;29(02):141–4. Li HH, Lou SJ. Effects of hypoxia on the expression of IL-1β、IL-6 and TNF-α mRNA in cerebral cortex cells of rats. Chin J Neuroanat. 2013;29(02):141–4.
50.
go back to reference Engelman JA, Luo J, Cantley LC. The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism. Nat Rev Genet. 2006;7(8):606–19.CrossRef Engelman JA, Luo J, Cantley LC. The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism. Nat Rev Genet. 2006;7(8):606–19.CrossRef
51.
go back to reference Hers I, Vincent EE, Tavaré JM. Akt signalling in health and disease. Cell Signal. 2011;23(10):1515–27.CrossRef Hers I, Vincent EE, Tavaré JM. Akt signalling in health and disease. Cell Signal. 2011;23(10):1515–27.CrossRef
52.
go back to reference Ye YT, Zhong W, Sun P, Wang D, Wang C, Hu LM, et al. Apoptosis induced by the methanol extract of Salvia miltiorrhiza Bunge in non-small cell lung cancer through PTEN-mediated inhibition of PI3K/Akt pathway. J Ethnopharmacol. 2017;200(undefined):107–16. Ye YT, Zhong W, Sun P, Wang D, Wang C, Hu LM, et al. Apoptosis induced by the methanol extract of Salvia miltiorrhiza Bunge in non-small cell lung cancer through PTEN-mediated inhibition of PI3K/Akt pathway. J Ethnopharmacol. 2017;200(undefined):107–16.
53.
go back to reference Chi QZ, Mellender SJ, Kiss GK, Liu X, Weiss HR. Blood -brain barrier disruption was less under isoflurane than pentobarbital anesthesia via a PI3K/Akt pathway in early cerebral ischemia. Brain Res Bull. 2017;131:1–6.CrossRef Chi QZ, Mellender SJ, Kiss GK, Liu X, Weiss HR. Blood -brain barrier disruption was less under isoflurane than pentobarbital anesthesia via a PI3K/Akt pathway in early cerebral ischemia. Brain Res Bull. 2017;131:1–6.CrossRef
54.
go back to reference Lin F, Xiaorong C, Jie Y, Jun Z, Chao W. Effect of electroacupuncture on NO, NOS and ET-1 in serum of rats with acute cerebral ischemia. Journal of Traditional Chinese Medicine University of Hunan. 2008;(01):67–69. Lin F, Xiaorong C, Jie Y, Jun Z, Chao W. Effect of electroacupuncture on NO, NOS and ET-1 in serum of rats with acute cerebral ischemia. Journal of Traditional Chinese Medicine University of Hunan. 2008;(01):67–69.
55.
go back to reference Jie S, Mingru Y, Yu Z, Xiaoxuan R, Yin L, Dengfang Z, Lufeng Z. Effect of early intervention of Xingnao Kaiqiao acupuncture therapy on SOD, MDA in rats with cerebral ischemia and reperfusion. China Journal of Traditional Chinese Medicine and Pharmacy. 2012;27(05):1397–400. Jie S, Mingru Y, Yu Z, Xiaoxuan R, Yin L, Dengfang Z, Lufeng Z. Effect of early intervention of Xingnao Kaiqiao acupuncture therapy on SOD, MDA in rats with cerebral ischemia and reperfusion. China Journal of Traditional Chinese Medicine and Pharmacy. 2012;27(05):1397–400.
57.
go back to reference S C, DP R, AP C, D S. Antioxidant therapy: a new pharmacological approach in shock, inflammation, and ischemia/reperfusion injury. Pharmacol Rev. 2001;53(1):135–59. S C, DP R, AP C, D S. Antioxidant therapy: a new pharmacological approach in shock, inflammation, and ischemia/reperfusion injury. Pharmacol Rev. 2001;53(1):135–59.
Metadata
Title
Network pharmacology exploration reveals a common mechanism in the treatment of cardio-cerebrovascular disease with Salvia miltiorrhiza Burge. and Carthamus tinctorius L
Authors
Yu Wang
Yajun Shi
Junbo Zou
Xiaofei Zhang
Yulin Liang
Jia Tai
Chunli Cui
Mei Wang
Dongyan Guo
Publication date
01-12-2020
Publisher
BioMed Central
Published in
BMC Complementary Medicine and Therapies / Issue 1/2020
Electronic ISSN: 2662-7671
DOI
https://doi.org/10.1186/s12906-020-03026-y

Other articles of this Issue 1/2020

BMC Complementary Medicine and Therapies 1/2020 Go to the issue